NeoGenomics, Inc. Made Big Gain
Thu, Apr 07, 2022 at 05:30 PM
NeoGenomics, Inc. (NEO:NASDAQ) rocketted at $13.97, a gain of 21.6%. On Wed, Apr 06, 2022, NEO:NASDAQ touched a New 2-Week Low of $11.49. The stock appeared on our News Catalysts scanner on Wed, Mar 30, 2022 at 09:52 AM in the 'MISCELLANEOUS' category. From Wed, Mar 23, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About NeoGenomics, Inc. (NEO:NASDAQ)
NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California and Nashville, and Tennessee.
Top 10 Gainers:
- MedAvail Holdings Inc. (MDVL:NASDAQ), 64.43%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 56.84%
- Momentus Inc. (MNTS:NASDAQ), 48.81%
- System1 Inc. Class A (SST:NYSE), 34.32%
- Vericity, Inc. (VERY:NASDAQ), 30.81%
- Ikena Oncology Inc. (IKNA:NASDAQ), 25.85%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 23.47%
- Alset EHome International Inc. (AEI:NASDAQ), 23.27%
- NeoGenomics, Inc. (NEO:NASDAQ), 21.58%